Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Lifestyle1966 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A49447 | 35747175 | EClinicalMedicine | The relationship between early weight loss and weight loss maintenance with naltrexone-bupropion therapy. | 2022 | Details |
| A49456 | 35745100 | Nutrients | Impact of Physical Activity Differences Due to COVID-19 Pandemic Lockdown on Non-Alcoholic Fatty Liver Parameters in Adults with Metabolic Syndrome. | 2022 | Details |
| A49457 | 35745097 | Nutrients | Exploring the Path of Mediterranean Diet, Non-Alcoholic Fatty Liver Disease (NAFLD) and Inflammation towards 10-Year Cardiovascular Disease (CVD) Risk: The ATTICA Study 10-Year Follow-Up (2002-2012). | 2022 | Details |
| A49465 | 35743870 | Life (Basel) | The Role of Macronutrients in the Pathogenesis, Prevention and Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Paediatric Population-A Review. | 2022 | Details |
| A49469 | 35743358 | J Clin Med | When Sugar Reaches the Liver: Phenotypes of Patients with Diabetes and NAFLD. | 2022 | Details |
| A49483 | 35740254 | Biomedicines | Effects of Thyroid Hormones on Lipid Metabolism Pathologies in Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A49513 | 35729970 | Curr Treat Options Gastroenterol | Liver Diseases in Latin America: Current Status, Unmet Needs, and Opportunities for Improvement. | 2022 | Details |
| A49514 | 35728963 | Cas Lek Cesk | Statins and liver. | 2022 | Details |
| A49515 | 35728962 | Cas Lek Cesk | An overview of current therapy options of non-alcoholic fatty liver disease. | 2022 | Details |
| A49572 | 35709779 | Acta Gastroenterol Belg | Non-invasive screening, staging and management of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus patients: what do we know so far ? | 2022 | Details |
| A49580 | 35706476 | Diabetes Metab Syndr Obes | Development of a Nomogram for Estimating the Risk of Left Ventricular Diastolic Dysfunction in Patients with Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A49631 | 35684997 | J Transcult Nurs | How Mexicans' Emotional Responses to Non-Alcoholic Fatty Liver Disease Can Help Inform Culturally Congruent Health Care. | 2022 | Details |
| A49635 | 35684022 | Nutrients | Effect of Dietary and Lifestyle Interventions on the Amelioration of NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study. | 2022 | Details |
| A49636 | 35683998 | Nutrients | Differential Effects of Dietary versus Exercise Intervention on Intrahepatic MAIT Cells and Histological Features of NAFLD. | 2022 | Details |
| A49638 | 35683987 | Nutrients | The Role of Phytosterols in Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A49650 | 35678936 | Plant Foods Hum Nutr | Hypolipidemic Effects of Soy Protein and Isoflavones in the Prevention of Non-Alcoholic Fatty Liver Disease- A Review. | 2022 | Details |
| A49675 | 35673598 | J Hepatocell Carcinoma | Hepatocellular Carcinoma Due to Nonalcoholic Fatty Liver Disease: Current Concepts and Future Challenges. | 2022 | Details |
| A49677 | 35673435 | J Diabetes Metab Disord | The triglyceride-glucose index as a clinical useful marker for metabolic associated fatty liver disease (MAFLD): a population-based study among Iranian adults. | 2022 | Details |
| A49696 | 35666879 | J Pediatr Gastroenterol Nutr | Insight Into the Adolescent Patient Experience With Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A49715 | 35660527 | Diabetes Metab | Exercise Reduces the Risk of Chronic Kidney Disease in Individuals with Nonalcoholic Fatty Liver Disease: A Nationwide Cohort Study. | 2022 | Details |
| A49727 | 35656562 | Diabetes Metab J | Lifestyle Interventions for Non-Obese Patients Both with, and at Risk, of Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A49750 | 35648467 | Am J Clin Nutr | Associations of serum n-3 and n-6 polyunsaturated fatty acids with prevalence and incidence of non-alcoholic fatty liver disease. | 2022 | Details |
| A49778 | 35640037 | Hum Reprod | Comparison of the cardiometabolic profiles of adolescents conceived through ART with those of a non-ART cohort. | 2022 | Details |
| A49796 | 35635757 | Liver Int | Clinical practice gaps and challenges in non-alcoholic steatohepatitis care: An international physician needs assessment. | 2022 | Details |
| A49797 | 35635048 | Ann Med | Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review. | 2022 | Details |
| A49818 | 35628889 | J Clin Med | Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome in Women: Effects of Lifestyle Modifications. | 2022 | Details |
| A49872 | 35613736 | BMJ Open Gastroenterol | Updated upper limit of normal for serum alanine aminotransferase value in Vietnamese population. | 2022 | Details |
| A49907 | 35600209 | Can J Gastroenterol Hepatol | Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease. | 2022 | Details |
| A49911 | 35599680 | Paediatr Child Health | Awareness, management, and practice patterns of pediatric NAFLD by primary care physicians. | 2021 | Details |
| A49921 | 35595482 | Prim Care | Diabetes-Associated Comorbidities. | 2022 | Details |
| A49946 | 35585687 | Clin Mol Hepatol | The Effect of Diabetes and Prediabetes on the Prevalence, Complications and Mortality in Non-alcoholic Fatty Liver Disease. | 2022 | Details |
| A49951 | 35584732 | Metabolism | A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. | 2022 | Details |
| A49958 | 35582982 | Obes Rev | The effect of pharmacological treatment and lifestyle modification in patients with nonalcoholic fatty liver disease: An umbrella review of meta-analyses of randomized controlled trials. | 2022 | Details |
| A49959 | 35582293 | World J Hepatol | Interrelationship between physical activity and depression in nonalcoholic fatty liver disease. | 2022 | Details |
| A49964 | 35581572 | BMC Pediatr | Epidemiology and lifestyle survey of non-alcoholic fatty liver disease in school-age children and adolescents in Shenyang, Liaoning. | 2022 | Details |
| A49988 | 35569886 | Endocr Pract | American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD). | 2022 | Details |
| A49999 | 35566790 | J Clin Med | Triglyceride-Glucose Index for Early Prediction of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of 121,975 Individuals. | 2022 | Details |
| A50004 | 35565780 | Nutrients | Effect of a Six-Month Lifestyle Intervention on the Physical Activity and Fitness Status of Adults with NAFLD and Metabolic Syndrome. | 2022 | Details |
| A50005 | 35565758 | Nutrients | Association between Stages of Hepatic Steatosis and Physical Activity Performance in Adults with Metabolic Syndrome: A Cross-Sectional Analysis in FLIPAN Study. | 2022 | Details |
| A50006 | 35565740 | Nutrients | A Low Glycemic Index Mediterranean Diet Combined with Aerobic Physical Activity Rearranges the Gut Microbiota Signature in NAFLD Patients. | 2022 | Details |
| A50013 | 35563534 | Int J Mol Sci | Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis. | 2022 | Details |
| A50060 | 35538852 | Acta Radiol | Improving data adequacy of ultrasonography reports for non-alcoholic fatty liver disease (NAFLD) through a national structured template. | 2022 | Details |
| A50064 | 35537911 | Rev Gastroenterol Mex (Engl Ed) | Prevalence and clinical-epidemiologic characteristics of a Mexican population with metabolic (dysfunction) associated fatty liver disease: An open population study. | 2022 | Details |
| A50123 | 35512974 | Fertil Steril | Nonalcoholic fatty liver disease and obstructive sleep apnea in women with polycystic ovary syndrome. | 2022 | Details |
| A50134 | 35508191 | Am J Physiol Cell Physiol | The role of mitochondria in the pathophysiology and treatment of common metabolic diseases in humans. | 2022 | Details |
| A50136 | 35507280 | Curr Atheroscler Rep | Comprehensive Review and Updates on Holistic Approach Towards Non-Alcoholic Fatty Liver Disease Management with Cardiovascular Disease. | 2022 | Details |
| A50137 | 35507279 | Curr Atheroscler Rep | Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50166 | 35494531 | Diabetes Metab Syndr Obes | Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome. | 2022 | Details |
| A50170 | 35492013 | Br J Nutr | A healthy lifestyle during adolescence was inversely associated with fatty liver indices in early adulthood - findings from the DONALD cohort study. | 2022 | Details |
| A50179 | 35488966 | Eur J Epidemiol | Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study. | 2022 | Details |
| A50187 | 35485207 | Hepatol Commun | A new detection system for serum fragmented cytokeratin 18 as a biomarker reflecting histologic activities of human nonalcoholic steatohepatitis. | 2022 | Details |
| A50210 | 35474232 | Hepatology | Association between birth weight, preterm birth, and nonalcoholic fatty liver disease in a community-based cohort. | 2022 | Details |
| A50214 | 35471471 | Front Med | Lingguizhugan Decoction, a Chinese herbal formula, improves insulin resistance in overweight/obese subjects with non-alcoholic fatty liver disease: a translational approach. | 2022 | Details |
| A50221 | 35467297 | Clin Drug Investig | General Overview About the Current Management of Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A50223 | 35465684 | Hypertension | Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk Factors. | 2022 | Details |
| A50226 | 35465068 | Gastroenterol Hepatol (N Y) | Nonalcoholic Fatty Liver Disease in Children. | 2021 | Details |
| A50239 | 35462330 | Biomed Pharmacother | Update of Indoles: Promising molecules for ameliorating metabolic diseases. | 2022 | Details |
| A50264 | 35449947 | ACS Omega | Polyphenol-Rich Extracts of Xylopia and Aframomum Species Show Metabolic Benefits by Lowering Hepatic Lipid Accumulation in Diet-Induced Obese Mice. | 2022 | Details |
| A50281 | 35444271 | Eur J Clin Nutr | Effect of intensive weight-loss intervention on metabolic, ultrasound and anthropometric parameters among patients with obesity and non-alcoholic fatty liver disease: an RCT. | 2022 | Details |
| A50282 | 35444259 | Sci Rep | Effects of exercise on NAFLD using non-targeted metabolomics in adipose tissue, plasma, urine, and stool. | 2022 | Details |
| A50294 | 35442241 | J Pediatr Gastroenterol Nutr | Insight Into the Adolescent Patient Experience With Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A50307 | 35437302 | Panminerva Med | A nutrigenetic tool for precision dietary management of NAFLD deeming insulin resistance markers. | 2022 | Details |
| A50377 | 35412016 | Clin Obes | The impact of health status, diet and lifestyle on non-alcoholic fatty liver disease: Narrative review. | 2022 | Details |
| A50383 | 35409465 | Int J Environ Res Public Health | Sclerocarya birrea (Marula) Extract Inhibits Hepatic Steatosis in db/db Mice. | 2022 | Details |
| A50411 | 35400330 | Endocr Metab Immune Disord Drug Targets | Literature Review on the Use of Herbal Extracts in the Treatment of Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50417 | 35399069 | BMC Endocr Disord | Lifestyle as well as metabolic syndrome and non-alcoholic fatty liver disease: an umbrella review of evidence from observational studies and randomized controlled trials. | 2022 | Details |
| A50435 | 35393310 | BMJ Open | Multisite prospective Liver Disease and Reproductive Ageing (LIVRA) study in US women living with and without HIV. | 2022 | Details |
| A50439 | 35392248 | Int J Endocrinol | Impact of Weight Reduction on Thyroid Function and Nonalcoholic Fatty Liver among Egyptian Adolescents with Obesity. | 2022 | Details |
| A50483 | 35368766 | Evid Based Complement Alternat Med | An Open-Label Exploratory Clinical Trial Evaluating the Effects of GLS (Coptidis Rhizoma-Evodiae Fructus 2 : 1) on Fibroblast Growth Factor 21 in Patients with Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A50500 | 35363906 | Hepatology | An international survey on patterns of practice in NAFLD and expectations for therapies-The POP-NEXT project. | 2022 | Details |
| A50513 | 35357066 | Liver Int | Impact of a Mediterranean diet on hepatic and metabolic outcomes in non-alcoholic fatty liver disease: The MEDINA randomised controlled trial. | 2022 | Details |
| A50514 | 35356532 | Front Cell Infect Microbiol | Therapeutic Potential of Natural Plants Against Non-Alcoholic Fatty Liver Disease: Targeting the Interplay Between Gut Microbiota and Bile Acids. | 2022 | Details |
| A50548 | 35345258 | Rev Cardiovasc Med | Cardiovascular events after liver transplantation: MACE hurts. | 2022 | Details |
| A50555 | 35343586 | Ann Hum Genet | Deleted genes associated with obesity in Mexican patients diagnosed with nonalcoholic fatty liver disease. | 2022 | Details |
| A50575 | 35334792 | Nutrients | Exosomal FZD-7 Expression Is Modulated by Different Lifestyle Interventions in Patients with NAFLD. | 2022 | Details |
| A50601 | 35328527 | Int J Mol Sci | SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection. | 2022 | Details |
| A50627 | 35322435 | J Food Biochem | Chia seeds and chemical-elicited sprouts supplementation ameliorates insulin resistance, dyslipidemia, and hepatic steatosis in obese rats. | 2022 | Details |
| A50702 | 35294774 | Eur J Clin Invest | The role of microbiota in nonalcoholic fatty liver disease. | 2022 | Details |
| A50707 | 35293152 | Hepatol Commun | Interactions of physical activity, muscular fitness, adiposity, and genetic risk for NAFLD. | 2022 | Details |
| A50721 | 35287643 | BMC Endocr Disord | Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. | 2022 | Details |
| A50746 | 35280674 | Int J Biol Sci | Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway. | 2022 | Details |
| A50752 | 35277756 | Eur J Nutr | Multidisciplinary lifestyle intervention is associated with improvements in liver damage and in surrogate scores of NAFLD and liver fibrosis in morbidly obese patients. | 2022 | Details |
| A50759 | 35276911 | Nutrients | Interaction between Lifestyle Changes and PNPLA3 Genotype in NAFLD Patients during the COVID-19 Lockdown. | 2022 | Details |
| A50764 | 35276001 | J Clin Endocrinol Metab | Endotoxin Biomarkers Are Associated With Adiposity and Cardiometabolic Risk Across 6 Years of Follow-up in Youth. | 2022 | Details |
| A50776 | 35269912 | Int J Mol Sci | Natural Compounds for Counteracting Nonalcoholic Fatty Liver Disease (NAFLD): Advantages and Limitations of the Suggested Candidates. | 2022 | Details |
| A50783 | 35268466 | J Clin Med | The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. | 2022 | Details |
| A50785 | 35268076 | Nutrients | The Effect of Dietary Interventions on Hypertriglyceridemia: From Public Health to Molecular Nutrition Evidence. | 2022 | Details |
| A50786 | 35268038 | Nutrients | Association between Physical Activity and Non-Alcoholic Fatty Liver Disease in Adults with Metabolic Syndrome: The FLIPAN Study. | 2022 | Details |
| A50788 | 35266164 | Aliment Pharmacol Ther | Review article: role of glucagon-like peptide-1 receptor agonists in non-alcoholic steatohepatitis, obesity and diabetes-what hepatologists need to know. | 2022 | Details |
| A50794 | 35263694 | Clin Nutr | Maternal polyunsaturated fatty acid concentrations during pregnancy and childhood liver fat accumulation. | 2022 | Details |
| A50830 | 35121749 | Sci Rep | A problem of proportions: estimates of metabolic associated fatty liver disease and liver fibrosis in Australian adults in the nationwide 2012 AusDiab Study. | 2022 | Details |
| A50912 | 33731597 | Eur J Gastroenterol Hepatol | Macro- and micronutrients in metabolic (dysfunction) associated fatty liver disease: association between advanced fibrosis and high dietary intake of cholesterol/saturated fatty acids. | 2021 | Details |
| A50999 | 27012655 | Atherosclerosis | Clinical research and methodology. The paradigm of fatty liver and atherosclerosis behind the chicken or the egg dilemma. | 2016 | Details |
| A51061 | 17911352 | Gut | Benefits of lifestyle modification in NAFLD. | 2007 | Details |
| A51102 | 35763235 | Dig Dis Sci | Intragastric Balloon in Obese Compensated Nonalcoholic Steatohepatitis Cirrhosis Patients Is Safe and Achieves Significant Weight Reduction at 6-Months. | 2022 | Details |
| A51111 | 35702368 | Int J Gen Med | Gallstone Disease and Bacterial Metabolic Performance of Gut Microbiota in Middle-Aged and Older Patients. | 2022 | Details |
| A51139 | 35516840 | J Toxicol Pathol | CD44 expression in the bile duct epithelium is related to hepatic fibrosis in nonalcoholic steatohepatitis rats induced by a choline-deficient, methionine-lowered, L-amino acid diet. | 2021 | Details |
| A51141 | 35511608 | Clin Infect Dis | HIV is associated with elevated FibroScan-AST (FAST) score. | 2022 | Details |
| A51155 | 35447624 | Nephron | Anything New in the Treatment of Obesity in Obese Patients with CKD? | 2022 | Details |
| A51185 | 35297334 | Exp Clin Transplant | How Exercise Affects the Development and Progression of Hepatocellular Carcinoma by Changing the Biomolecular Status of the Tumor Microenvironment. | 2022 | Details |